Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)

Published:2023-01-16 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Kwee Kevin V.¹,Murk Jean-Luc²^ORCID,Yin Qiqi¹,Visch M. Birgitte³,Davidson Linda⁴,de Jong Elke M. G. J.⁵^ORCID,van den Reek Juul M. P. A.⁵,Tjioe Milan¹

Affiliation:

1. Department of Dermatology/DermaTeam Research, Bravis Hospital, Roosendaal, The Netherlands

2. Elisabeth Tweesteden Hospital, Microvida, Tilburg, The Netherlands

3. Department of Dermatology, Rijnstate Hospital, Arnhem, The Netherlands

4. Independent Infectious Disease specialist, Nijmegen, The Netherlands

5. Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2022.2161297

Reference25 articles.

2. Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration

3. The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

4. COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain

5. Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis healthcare during the COVID-19 pandemic: a survey among psoriasis patients (PsoCovidCare);Journal of Dermatological Treatment;2024-06-19

2. Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a cross-sectional survey;Scientific Reports;2024-03-15

3. Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China;Heliyon;2024-01

4. A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting;Immunity, Inflammation and Disease;2023-11

5. COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?;Journal of Cosmetic Dermatology;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3